Evidence map›Paper›PMID 41857117›Full record

ArticleScientific reports2026

Correction: Revisiting the link between COVID-19 incidence and infection fatality rate during the first pandemic wave.

Benjamin Glemain, Charles Assaad, Walid Ghosn, Paul Moulaire, Xavier de Lamballerie, Marie Zins, Gianluca Severi, Mathilde Touvier, Jean-François Deleuze, SAPRIS-SERO study group and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Benjamin GlemainDépartement de santé publique, Sorbonne Université, Inserm, Institut Pierre-Louis d'épidémiologie et de santé publique, AP-HP, Hôpital Saint-Antoine, Paris, 75012, France. benjamin.glemain@ipslep.upmc.fr.
Charles AssaadInserm, Institut Pierre-Louis d'épidémiologie et de santé publique, Sorbonne Université, 75012, Paris, France.
Walid GhosnCentre d'épidémiologie sur les causes médicales de décès de l'Inserm-CépiDc, Paris, France.
Paul MoulaireInserm, Institut Pierre-Louis d'épidémiologie et de santé publique, Sorbonne Université, 75012, Paris, France.
Xavier de LamballerieUnité des Virus Émergents, Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, Marseille, France.
Marie ZinsParis University, Paris, France.
Gianluca SeveriCESP UMR1018, Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, Villejuif, France.
Mathilde TouvierSorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center - University of Paris (CRESS), Bobigny, France.
Jean-François DeleuzeFondation Jean Dausset-CEPH (Centre d'Etude du Polymorphisme Humain), CEPH-Biobank, Paris, France.
SAPRIS-SERO study group
Nathanaël Lapidus *Département de santé publique, Sorbonne Université, Inserm, Institut Pierre-Louis d'épidémiologie et de santé publique, AP-HP, Hôpital Saint-Antoine, Paris, 75012, France.
Fabrice Carrat *Département de santé publique, Sorbonne Université, Inserm, Institut Pierre-Louis d'épidémiologie et de santé publique, AP-HP, Hôpital Saint-Antoine, Paris, 75012, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41857117
PMCPMC13003022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.